Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:57 pm Sale | 13G | ZENTALIS PHARMACEUTICALS INC C ZNTL | CITADEL ADVISORS LLC | 3,738,482 5.3% | -101,347 (-2.64%) | View |
| 2024-02-13 7:43 pm Sale | 13G | ZENTALIS PHARMACEUTICALS INC C ZNTL | Avidity Partners Management LP | 0 0% | -5,150,000 (Position Closed) | View |
| 2024-02-13 5:17 pm Purchase | 13G | ZENTALIS PHARMACEUTICALS INC C ZNTL | VANGUARD GROUP INC | 5,350,458 7.56% | 1,190,309 (+28.61%) | View |
| 2024-02-09 6:05 pm Sale | 13G | ZENTALIS PHARMACEUTICALS INC C ZNTL | Capital International Investors | 2,819,664 4% | -228,518 (-7.50%) | View |
| 2024-02-09 10:05 am Purchase | 13G | ZENTALIS PHARMACEUTICALS INC C ZNTL | FMR LLC | 10,336,971 14.607% | 2,427,795 (+30.70%) | View |
| 2024-02-09 08:40 am Sale | 13G | ZENTALIS PHARMACEUTICALS INC C ZNTL | WELLINGTON MANAGEMENT GROUP LLP | 68,791 0.1% | -3,549,702 (-98.10%) | View |
| 2024-01-29 3:26 pm Purchase | 13G | ZENTALIS PHARMACEUTICALS INC C ZNTL | BlackRock Inc. BLK | 4,684,975 6.6% | 1,212,796 (+34.93%) | View |
| 2024-01-25 07:52 am Purchase | 13G | ZENTALIS PHARMACEUTICALS INC C ZNTL | STATE STREET CORP STT | 4,417,056 6.24% | 1,332,919 (+43.22%) | View |
| 2023-12-11 5:15 pm Purchase | 13G | ZENTALIS PHARMACEUTICALS INC C ZNTL | EVENTIDE ASSET MANAGEMENT LLC | 11,559,975 16.34% | 3,745,936 (+47.94%) | View |
| 2023-11-17 5:12 pm Purchase | 13G | ZENTALIS PHARMACEUTICALS INC C ZNTL | CITADEL ADVISORS LLC | 3,839,829 5.4% | 2,335,959 (+155.33%) | View |
| 2023-10-10 3:40 pm Purchase | 13G | ZENTALIS PHARMACEUTICALS INC C ZNTL | EVENTIDE ASSET MANAGEMENT LLC | 7,814,039 11.07% | 7,814,039 (New Position) | View |
| 2023-06-20 4:30 pm Purchase | 13D | ZENTALIS PHARMACEUTICALS INC C ZNTL | Matrix Capital Management Company LP | 13,959,973 19.81% | 4,760,000 (+51.74%) | View |
| 2023-03-09 7:16 pm Sale | 13G | ZENTALIS PHARMACEUTICALS INC C ZNTL | SUN ANTHONY Y | 360,542 0.6% | -2,631,365 (-87.95%) | View |
| 2023-02-14 12:38 pm Sale | 13G | ZENTALIS PHARMACEUTICALS INC C ZNTL | PRICE T ROWE ASSOCIATES INC | 2,176,700 3.8% | -2,206,181 (-50.34%) | View |
| 2023-02-14 12:02 pm Purchase | 13G | ZENTALIS PHARMACEUTICALS INC C ZNTL | Avidity Partners Management LP | 5,150,000 9% | 2,127,210 (+70.37%) | View |
| 2023-02-14 10:52 am Sale | 13G | ZENTALIS PHARMACEUTICALS INC C ZNTL | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,231,427 3.9% | -396,982 (-15.10%) | View |
| 2023-02-13 3:54 pm Purchase | 13G | ZENTALIS PHARMACEUTICALS INC C ZNTL | Capital International Investors | 3,048,182 5.3% | 3,048,182 (New Position) | View |
| 2023-02-09 12:46 pm Purchase | 13G | ZENTALIS PHARMACEUTICALS INC C ZNTL | FMR LLC | 7,909,176 13.858% | 1,113,345 (+16.38%) | View |
| 2023-02-09 11:37 am Purchase | 13G | ZENTALIS PHARMACEUTICALS INC C ZNTL | VANGUARD GROUP INC | 4,160,149 7.29% | 973,163 (+30.54%) | View |
| 2023-02-07 1:20 pm Purchase | 13G | ZENTALIS PHARMACEUTICALS INC C ZNTL | STATE STREET CORP STT | 3,084,137 5.4% | 3,084,137 (New Position) | View |